---
title: "Byhealth Co.,Ltd (300146.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300146.SZ.md"
symbol: "300146.SZ"
name: "Byhealth Co.,Ltd"
industry: "Personal Care Products"
datetime: "2026-05-21T03:16:56.740Z"
locales:
  - [en](https://longbridge.com/en/quote/300146.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300146.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300146.SZ.md)
---

# Byhealth Co.,Ltd (300146.SZ)

## Company Overview

Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management; and OTC licensing and outsourced processing activities. It sells its products through retail terminals, such as pharmacies, supermarkets, and maternity and baby stores, as well as distributors; and e-commerce platforms comprising Tmall, JD.com, Vipshop, Douyin, and Kuaishou.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | CN Market |
| Website | [www.by-health.com](https://www.by-health.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: B (0.37)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 28 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 5.99% |  |
| Net Profit YoY | 91.52% |  |
| P/B Ratio | 1.49 |  |
| Dividend Ratio | 4.39% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 17201063166.57 |  |
| Revenue | 6353875734.15 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.33% | C |
| Profit Margin | 11.50% | B |
| Gross Margin | 69.15% | A |
| Revenue YoY | 5.99% | C |
| Net Profit YoY | 91.52% | A |
| Total Assets YoY | 0.50% | C |
| Net Assets YoY | 0.32% | C |
| Cash Flow Margin | 123.92% | B |
| OCF YoY | 5.99% | C |
| Turnover | 0.45 | C |
| Gearing Ratio | 17.61% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Byhealth Co.,Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "5.99%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "91.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.49",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "4.39%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "17201063166.57",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6353875734.15",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.33%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "11.50%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "69.15%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "5.99%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "91.52%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.50%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.32%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "123.92%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "5.99%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.45",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "17.61%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 23.29 | 4/28 | 50.02 | 30.70 | 28.45 |
| PB | 1.47 | 4/28 | 1.86 | 1.77 | 1.68 |
| PS (TTM) | 2.68 | 13/28 | 3.53 | 3.38 | 3.19 |
| Dividend Yield | 4.44% | 1/28 | 3.17% | 3.02% | 2.91% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Proya (603605.SH) | A | D | A | B | C | B |
| 02 | BYHEALTH (300146.SZ) | B | C | C | A | C | B |
| 03 | BTN (300957.SZ) | B | C | B | B | C | B |
| 04 | FLYCO (603868.SH) | A | D | A | A | C | B |
| 05 | Shanghai Jahwa (600315.SH) | C | B | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-26T16:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 80% |
| Hold | 1 | 20% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.10 |
| Highest Target | 14.56 |
| Lowest Target | 10.30 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300146.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300146.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300146.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300146.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**